135 related articles for article (PubMed ID: 25296412)
1. [FRancilian Oncogeriatric Group (FROG)'s focus on management of elderly patients with bladder cancer].
Ghebriou D; Avenin D; Caillet P; Mongiat-Artus P; Durdux C; Massard C; Culine S
Bull Cancer; 2014 Sep; 101(9):841-55. PubMed ID: 25296412
[TBL] [Abstract][Full Text] [Related]
2. Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit.
VanderWalde NA; Chi MT; Hurria A; Galsky MD; Nielsen ME
World J Urol; 2016 Jan; 34(1):3-11. PubMed ID: 26497825
[TBL] [Abstract][Full Text] [Related]
3. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
Tran E; Souhami L; Tanguay S; Rajan R
Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
[TBL] [Abstract][Full Text] [Related]
4. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.
Hamaker ME; Seynaeve C; Wymenga AN; van Tinteren H; Nortier JW; Maartense E; de Graaf H; de Jongh FE; Braun JJ; Los M; Schrama JG; van Leeuwen-Stok AE; de Groot SM; Smorenburg CH
Breast; 2014 Feb; 23(1):81-7. PubMed ID: 24314824
[TBL] [Abstract][Full Text] [Related]
5. Bladder cancer in the elderly patient: challenges and solutions.
Guancial EA; Roussel B; Bergsma DP; Bylund KC; Sahasrabudhe D; Messing E; Mohile SG; Fung C
Clin Interv Aging; 2015; 10():939-49. PubMed ID: 26089655
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
7. [Infiltrating cancer of the bladder: can radiochemotherapy be an alternative to cystectomy?].
Chrétien Y; Mejean A; Durdux C; Dufour B; Housset M
J Urol (Paris); 1996; 102(1):3-8. PubMed ID: 8763598
[TBL] [Abstract][Full Text] [Related]
8. Association of statin use with improved local control in patients treated with selective bladder preservation for muscle-invasive bladder cancer.
Tsai HK; Katz MS; Coen JJ; Zietman AL; Kaufman DS; Shipley WU
Urology; 2006 Dec; 68(6):1188-92. PubMed ID: 17141846
[TBL] [Abstract][Full Text] [Related]
9. Selection of treatment for muscle infiltrating transitional cell bladder cancer.
Whitmore WF
Arch Esp Urol; 1990; 43 Suppl 2():219-22. PubMed ID: 2096783
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of two prospective bladder-sparing trimodality approaches for invasive bladder cancer: neoadjuvant chemotherapy and concurrent radio-chemotherapy.
Zapatero A; Martin De Vidales C; Arellano R; Ibañez Y; Bocardo G; Perez M; Rabadan M; García Vicente F; Cruz Conde JA; Olivier C
Urology; 2012 Nov; 80(5):1056-62. PubMed ID: 22999456
[TBL] [Abstract][Full Text] [Related]
11. Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.
Koukourakis MI; Tsolos C; Touloupidis S
Urology; 2007 Feb; 69(2):245-50. PubMed ID: 17320657
[TBL] [Abstract][Full Text] [Related]
12. The optimal management of T1G3 bladder cancer.
Emiliozzi P; Pansadoro A; Pansadoro V
BJU Int; 2008 Nov; 102(9 Pt B):1265-73. PubMed ID: 19035891
[No Abstract] [Full Text] [Related]
13. Bladder cancer: a review of diagnosis and management.
Metts MC; Metts JC; Milito SJ; Thomas CR
J Natl Med Assoc; 2000 Jun; 92(6):285-94. PubMed ID: 10918764
[TBL] [Abstract][Full Text] [Related]
14. Detecting and treating bladder cancer.
Anderson B
Br J Nurs; 2013 Jun 13-26; 22(11):628. PubMed ID: 23899731
[No Abstract] [Full Text] [Related]
15. Combined radiotherapy, chemotherapy and surgery in the management of invasive bladder cancer.
Jakse G; Frommhold H
Prog Clin Biol Res; 1988; 269():591-600. PubMed ID: 3393556
[No Abstract] [Full Text] [Related]
16. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of bladder cancer.
Sharma S; Ksheersagar P; Sharma P
Am Fam Physician; 2009 Oct; 80(7):717-23. PubMed ID: 19817342
[TBL] [Abstract][Full Text] [Related]
18. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
[TBL] [Abstract][Full Text] [Related]
19. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.
Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR
Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562
[TBL] [Abstract][Full Text] [Related]
20. Bladder cancer.
Gwynn ES; Clark PE
Curr Opin Oncol; 2006 May; 18(3):277-83. PubMed ID: 16552241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
